Harare City Health Department, Harare, Zimbabwe Report issue

Government Phase 2

Organization Overview

First Clinical Trial
1997
NCT00198718
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1997

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

vitamin a (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Night Blindness (Phase 2)

Vitamin A Deficiency (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1